H. A. M. van Kesteren

Author

Also Known As

H A M van Kesteren, H. A. M. van Kesteren, H.A.M Van Kesteren, H.A.M. van Kesteren, Henri A.M. van Kesteren

Publications

196

Citations

H-Index

Concepts

All Affiliations

H. A. M. van Kesteren is an author at Maastricht University specializing in pharmacotherapy, translational medicine, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	31
2	Pharmacology	1	1	31
3	Pharmacotherapy	1	1	31
4	Thrombosis	1	1	31
5	Translational Medicine	1	1	31

H. A. M. van Kesteren

Publications

179

Citations

H-Index

Page 1

	Year	Citations
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study M T H M Henkens, AG Raafs, Job A.J. Verdonschot, BMC Geriatrics	2022	68
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries Marijke Linschoten, Alicia Uijl, Astrid Schut, European Heart Journal	2021	55
Combined therapy with streptokinase and integrilin Eelko Ronner, H. A. M. van Kesteren, P. Zijnen, Journal of the American College of Cardiology ThrombosisTranslational MedicinePharmacologyPharmacotherapyMedicine	1998	31
Screening for paroxysmal atrial fibrillation in primary care using Holter monitoring and intermittent, ambulatory single-lead electrocardiography Evert P.M. Karregat, Nicole Verbiest-van Gurp, Anne C. Bouwman, International Journal of Cardiology	2021	15
How do Dutch general practitioners detect and diagnose atrial fibrillation? Results of an online case vignette study Nicole Verbiest-van Gurp, Dominique van Mil, H. A. M. van Kesteren, BMC Family Practice	2019	10

Page 1